Literature DB >> 21984545

Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.

Anuradha Kalyanasundaram1, Serge Viatchenko-Karpinski, Andriy E Belevych, Veronique A Lacombe, Hyun Seok Hwang, Björn C Knollmann, Sandor Gyorke, Muthu Periasamy.   

Abstract

The role of calsequestrin (CASQ2) in cardiac sarcoplasmic reticulum (SR) calcium (Ca(2+)) transport has gained significant attention since point mutations in CASQ2 were reported to cause ventricular arrhythmia. In the present study, we have critically evaluated the functional consequences of expressing the CASQ2(D307H) mutant protein in the CASQ2 null mouse. We recently reported that the mutant CASQ2(D307H) protein can be stably expressed in CASQ2 null hearts, and it targets appropriately to the junctional SR (Kalyanasundaram A, Bal NC, Franzini-Armstrong C, Knollmann BC, Periasamy M. J Biol Chem 285: 3076-3083, 2010). In this study, we found that introduction of CASQ2(D307H) protein in the CASQ2 null background partially restored triadin 1 levels, which were decreased in the CASQ2 null mice. Despite twofold expression (relative to wild-type CASQ2), the mutant protein failed to increase SR Ca(2+) load. We also found that the Ca(2+) transient decays slower in the CASQ2 null and CASQ2(D307H) cells. CASQ2(D307H) myocytes, when rhythmically paced and challenged with isoproterenol, exhibit spontaneous Ca(2+) waves similar to CASQ2 null myocytes; however, the stability of Ca(2+) cycling was increased in the CASQ2(D307H) myocytes. In the presence of isoproterenol, Ca(2+)-transient amplitude in CASQ2(D307H) myocytes was significantly decreased, possibly indicating an inherent defect in Ca(2+) buffering capacity and release from the mutant CASQ2 at high Ca(2+) concentrations. We also observed polymorphic ventricular tachycardia in the CASQ2(D307H) mice, although lesser than in the CASQ2 null mice. These data suggest that CASQ2(D307H) point mutation may affect Ca(2+) buffering capacity and Ca(2+) release. We propose that poor interaction between CASQ2(D307H) and triadin 1 could affect ryanodine receptor 2 stability, thereby increasing susceptibility to delayed afterdepolarizations and triggered arrhythmic activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21984545      PMCID: PMC3334241          DOI: 10.1152/ajpheart.00578.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  37 in total

1.  Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity.

Authors:  Qunying Yuan; Guo-Chang Fan; Min Dong; Beth Altschafl; Abhinav Diwan; Xiaoping Ren; Harvey H Hahn; Wen Zhao; Jason R Waggoner; Larry R Jones; W Keith Jones; Donald M Bers; Gerald W Dorn; Hong-Sheng Wang; Héctor H Valdivia; Guoxiang Chu; Evangelia G Kranias
Journal:  Circulation       Date:  2007-01-15       Impact factor: 29.690

2.  Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane.

Authors:  L Zhang; J Kelley; G Schmeisser; Y M Kobayashi; L R Jones
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

3.  Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Björn C Knollmann; Nagesh Chopra; Thinn Hlaing; Brandy Akin; Tao Yang; Kristen Ettensohn; Barbara E C Knollmann; Kenneth D Horton; Neil J Weissman; Izabela Holinstat; Wei Zhang; Dan M Roden; Larry R Jones; Clara Franzini-Armstrong; Karl Pfeifer
Journal:  J Clin Invest       Date:  2006-08-24       Impact factor: 14.808

4.  Biochemical characterization of ultrastructural localization of a major junctional sarcoplasmic reticulum glycoprotein (triadin).

Authors:  C M Knudson; K K Stang; A O Jorgensen; K P Campbell
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

5.  Modulation of sarcoplasmic reticulum calcium release by calsequestrin in cardiac myocytes.

Authors:  Sandor Györke; Inna Györke; Dmitry Terentyev; Serge Viatchenko-Karpinski; Simon C Williams
Journal:  Biol Res       Date:  2004       Impact factor: 5.612

6.  Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin.

Authors:  L R Jones; Y J Suzuki; W Wang; Y M Kobayashi; V Ramesh; C Franzini-Armstrong; L Cleemann; M Morad
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

Review 7.  SERCA pump isoforms: their role in calcium transport and disease.

Authors:  Muthu Periasamy; Anuradha Kalyanasundaram
Journal:  Muscle Nerve       Date:  2007-04       Impact factor: 3.217

8.  Association of triadin with the ryanodine receptor and calsequestrin in the lumen of the sarcoplasmic reticulum.

Authors:  W Guo; K P Campbell
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

9.  Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice.

Authors:  Y Sato; D G Ferguson; H Sako; G W Dorn; V J Kadambi; A Yatani; B D Hoit; R A Walsh; E G Kranias
Journal:  J Biol Chem       Date:  1998-10-23       Impact factor: 5.157

10.  A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.

Authors:  Wessel P Dirksen; Veronique A Lacombe; Mei Chi; Anuradha Kalyanasundaram; Serge Viatchenko-Karpinski; Dmitry Terentyev; Zhixiang Zhou; Srikanth Vedamoorthyrao; Ning Li; Nipavan Chiamvimonvat; Cynthia A Carnes; Clara Franzini-Armstrong; Sandor Györke; Muthu Periasamy
Journal:  Cardiovasc Res       Date:  2007-03-12       Impact factor: 10.787

View more
  7 in total

1.  Interplay between Triadin and Calsequestrin in the Pathogenesis of CPVT in the Mouse.

Authors:  Marine Cacheux; Jérémy Fauconnier; Jérôme Thireau; Alexis Osseni; Jacques Brocard; Nathalie Roux-Buisson; Julie Brocard; Julien Fauré; Alain Lacampagne; Isabelle Marty
Journal:  Mol Ther       Date:  2019-09-13       Impact factor: 11.454

Review 2.  Calsequestrin 2 and arrhythmias.

Authors:  Michela Faggioni; Björn C Knollmann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-23       Impact factor: 4.733

Review 3.  The function and regulation of calsequestrin-2: implications in calcium-mediated arrhythmias.

Authors:  Elliot T Sibbles; Helen M M Waddell; Valeria Mereacre; Peter P Jones; Michelle L Munro
Journal:  Biophys Rev       Date:  2022-01-07

4.  Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1.

Authors:  Alexey V Glukhov; Anuradha Kalyanasundaram; Qing Lou; Lori T Hage; Brian J Hansen; Andriy E Belevych; Peter J Mohler; Björn C Knollmann; Muthu Periasamy; Sandor Györke; Vadim V Fedorov
Journal:  Eur Heart J       Date:  2013-11-11       Impact factor: 29.983

5.  Exposure to phthalates affects calcium handling and intercellular connectivity of human stem cell-derived cardiomyocytes.

Authors:  Nikki Gillum Posnack; Rabia Idrees; Hao Ding; Rafael Jaimes; Gulnaz Stybayeva; Zaruhi Karabekian; Michael A Laflamme; Narine Sarvazyan
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

6.  Graded Maximal Exercise Testing to Assess Mouse Cardio-Metabolic Phenotypes.

Authors:  Jennifer M Petrosino; Valerie J Heiss; Santosh K Maurya; Anuradha Kalyanasundaram; Muthu Periasamy; Richard A LaFountain; Jacob M Wilson; Orlando P Simonetti; Ouliana Ziouzenkova
Journal:  PLoS One       Date:  2016-02-09       Impact factor: 3.240

7.  Insights into the genetic variation of maternal behavior and suckling performance of continental beef cows.

Authors:  Alexis Michenet; Romain Saintilan; Eric Venot; Florence Phocas
Journal:  Genet Sel Evol       Date:  2016-06-22       Impact factor: 4.297

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.